Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 1-year average of -486.57%, near the high end of its 1-year range (-1716.17%–0.00%).
100.00% above its 12-month average of -486.57%.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-06-30): -583.54%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
-486.57%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Citius Oncology, Inc.
Market Cap
$81.82M
Operating Margin
0.00%
TTM Avg
-486.57%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$84.17M
Operating Margin
-3242.47%
TTM Avg
-1621.23%
3Y Avg
-1058.13%
5Y Avg
-747.59%
Market Cap
$84.87M
Operating Margin
-5271.69%
TTM Avg
-2635.84%
3Y Avg
-2669.01%
5Y Avg
-3573.08%
Market Cap
$84.52M
Operating Margin
29.69%
TTM Avg
-17.51%
3Y Avg
-923.94%
5Y Avg
-894.93%
Market Cap
$81.67M
Operating Margin
-42.06%
TTM Avg
-31.00%
3Y Avg
-37.02%
5Y Avg
-45.87%
Market Cap
$85.90M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$81.10M
Operating Margin
-52.96%
TTM Avg
-64.09%
3Y Avg
-81.91%
5Y Avg
-87.35%
Market Cap
$85.18M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$79.80M
Operating Margin
-132871.32%
TTM Avg
-92244.12%
3Y Avg
-51098.97%
5Y Avg
-37173.74%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Oncology, Inc. (CTOR) | $81.82M | 0.00% | -486.57% | 0.00% | N/A |
| MediciNova, Inc. (MNOV)vs › | $84.17M | -3242.47% | -1621.23% | -1058.13% | -747.59% |
| Humacyte, Inc. (HUMA)vs › | $84.87M | -5271.69% | -2635.84% | -2669.01% | -3573.08% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.52M | 29.69% | -17.51% | -923.94% | -894.93% |
| LENSAR Inc (LNSR)vs › | $81.67M | -42.06% | -31.00% | -37.02% | -45.87% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.90M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulmonx Corporation (LUNG)vs › | $81.10M | -52.96% | -64.09% | -81.91% | -87.35% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.80M | -132871.32% | -92244.12% | -51098.97% | -37173.74% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.48M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -583.54% |
| 2026-03-31 | -1716.17% |
| 2025-12-31 | -133.17% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
